Seeking Alpha

More on Ilumina (ILMN): Q1 beats across the board despite a slight decline in Y/Y revenue. Net...

More on Ilumina (ILMN): Q1 beats across the board despite a slight decline in Y/Y revenue. Net earnings actually rose 8.6% as the diagnostics company chalked up lower expenses to offset the revenue dip. Additionally, the company's board authorized a $250M share repurchase. Shares -0.8% AH.
From other sites
Comments (1)
  • Mike Maher
    , contributor
    Comments (2828) | Send Message
     
    Instead of selling to Roche @ $51 management is going to start buying shares at 43? Where was the buyback in December with shares in the low $30s?
    23 Apr 2012, 10:52 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs